Brief: Nanthealth reports strong 2016 Q2 revenues and continued progress on GPS Cancer and nantos platform

Nanthealth

09/08/2016 21:15

Aug 9 (Reuters) - Nanthealth Reports Strong 2016 Second 
 NH.O  
    * Q2 adjusted non-GAAP loss per share $0.15 
    * Q2 earnings per share view $-0.42 -- Thomson Reuters 
I/B/E/S 
    * Q2 loss per share $0.52 
    * Quarter revenues and continued progress on GPS Cancer and 
nantos platform 
    * Q2 revenue rose 167 percent to $31.5 million 
    * Q2 revenue view $23.5 million -- Thomson Reuters I/B/E/S 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw70dbKVa 
Further company coverage:  NH.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))